Skip to main content
. 2020 Apr 5;14:717–724. doi: 10.2147/PPA.S245324

Table 2.

Result of Cox Regression Analyses for Primary Outcome After Percutaneous Coronary Intervention

Variable Univariate Multivariate
Unadjusted HR [95% CI] p-value Adjusted HR [95% CI] p-value
Time-fixed variables
Sex, male 0.98 [0.88–1.08] 0.646 1.06 [0.95–1.19] 0.292
Age, per 5 years 1.07 [1.05–1.10] < 0.001 1.07 [1.04–1.10] < 0.001
Hypertension 1.09 [0.93–1.27] 0.302 1.02 [0.87–1.20] 0.082
Diabetes mellitus 1.34 [1.20–1.48] < 0.001 1.33 [1.19–1.47] < 0.001
Atrial fibrillation 1.27 [1.08–1.50] < 0.001 1.16 [0.98–1.37] 0.090
Myocardial infarction 1.42 [1.28–1.57] < 0.001 1.42 [1.29–1.58] < 0.001
Household Income
 Low 1 (Ref) 1 (Ref)
 Middle 0.99 [0.87–1.12] 0.863 1.03 [0.91–1.17] 0.637
 High 1.05 [0.92–1.19] 0.456 1.08 [0.95–1.23] 0.243
Time-dependent Variables
Antiplatelets
 No aspirin, no ADPRB 1 (Ref) 1 (Ref)
 Aspirin only 0.49 [0.42–0.57] < 0.001 0.71 [0.59–0.85] < 0.001
 ADPRB only 0.58 [0.46–0.72] < 0.001 0.82 [0.64–1.05] 0.120
 Aspirin plus ADPRB 0.69 [0.60–0.80] < 0.001 1.03 [0.86–1.23] 0.730
Statins
 No statin 1 (Ref) 1 (Ref)
 Statin use 0.69 [0.62–0.78] < 0.001 0.72 [0.63–0.81] < 0.001
 Withdrawal 1.90 [1.56–2.32] < 0.001 1.87 [1.52–2.29] < 0.001

Note: Data are derived from multivariate time-dependent Cox proportional hazard regression model.

Abbreviations: ADPRB, adenosine diphosphate receptor blocker (clopidogrel, prasugrel, ticlopidine, ticagrelor); CI, confidence interval; HR, hazard ratio.